Skip to main content
Article
Breaking B and T cell tolerance using cationic lipid--DNA complexes (CLDC) as a vaccine adjuvant with hepatitis B virus (HBV) surface antigen in transgenic mice expressing HBV
Antiviral Research
  • John D Morrey, Utah State University
  • N E Motter
  • S Chang
  • J Fairman
Document Type
Article
Publication Date
1-1-2011
Citation Information
Morrey, J. D., N. E. Motter, S. Chang, and J. Fairman. 2011. Breaking B and T cell tolerance using cationic lipid--DNA complexes (CLDC) as a vaccine adjuvant with hepatitis B virus (HBV) surface antigen in transgenic mice expressing HBV. Antiviral Research 90:227-230. PMID21545812 PMC3117788